Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Fina...
03/14/19
Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Company achieves FY 2018 total net revenues of $130.4 million; FY 2018 operating expenses reduced by $27.2 million, or 18.4%. VANCOUVER, British ...
[more]